Cancer-Associated Hypercalcemia
Theresa A. Guise, John J. Wysolmerski
Abstract
Cancer-associated hypercalcemia often occurs late in the course of solid-tumor development and is associated with a poor prognosis. Treatment includes intravenous hydration followed by antiresorptive agents, typically intravenous bisphosphonates. Successful management ultimately depends on effective treatment of the underlying cancer.
Topics & Concepts
MedicineCancerDenosumabInternal medicineIntensive care medicineOncologyOsteoporosisBone health and treatmentsBone and Joint DiseasesCancer Diagnosis and Treatment